Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

NCT02004067 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Primary Sjogren Syndrome
Secondary Sjogren Syndrome
Aqueous Deficient Dry Eye Disease
Evaporative Dry Eye Disease

Interventions

DRUG: Restasis
DRUG: Refresh Endura

Sponsor

Federal University of São Paulo

Collaborators

[object Object]